Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Quintiles Restructures Early Development/Lab Services Division

This article was originally published in The Pink Sheet Daily

Executive Summary

The division has underperformed in 2004, although recent business win trends are “encouraging,” CFO Ratliff says. The contract research and sales organization believes that underlying demand for its services remains strong, particularly in the product development area.

You may also be interested in...



Quintiles Cymbalta Promotion Expenses Ramping Up; Revenue To Follow

The company expects a 500-plus person sales force hired for the Cymbalta launch to cost $6 mil.-$7 mil. a month over the quarter. A $10 mil. milestone to Lilly is also expected to "hit this quarter."

Quintiles Cymbalta Promotion Expenses Ramping Up; Revenue To Follow

The company expects a 500-plus person sales force hired for the Cymbalta launch to cost $6 mil.-$7 mil. a month over the quarter. A $10 mil. milestone to Lilly is also expected to "hit this quarter."

Aventis Must Divest Estorra Rights For FTC Green Light On Sanofi Merger

Aventis has 90 days to sell rights to the insomnia agent back to Sepracor or another buyer approved by the Federal Trade Commission. The agency says Estorra would overlap with Sanofi’s Ambien.

Topics

UsernamePublicRestriction

Register

PS060300

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel